ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

QDEL vs ACHV // EV/EBITDA & P/E VALUATION

QuidelOrtho Corporation (NASDAQ) VS. Achieve Life Sciences Inc. (NASDAQ) • 15-METRIC TALLY: QDEL 3 — ACHV 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QDEL VS. ACHV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC QDEL ACHV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -8.80% -6.69% -2.11 ACHV /fcf-yield <GO>
Operating Margin -33.70% — — TIE /operating-margins <GO>
Net Profit Margin -41.50% — — TIE /net-margins <GO>
Revenue Growth (YoY) -1.90% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 QDEL /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 55.3 53.2 +2.10 QDEL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $943.6M $739.9M $203.7M QDEL /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR QDEL REV ACHV REV QDEL GROSS % ACHV GROSS % QDEL FCF ACHV FCF
FY 2025 $2.73B $0 — — -$83.0M -$49.5M
FY 2024 $2.78B $0 — — -$112.1M -$29.8M
FY 2023 $3.00B $0 — — $280.2M -$24.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QDEL // BETA —
ACHV // BETA —